Speaker Profile

Ph.D., Director of Business Development, Collaborative Drug Discovery

Biography
Whitney earned a PhD from UC Berkeley in 1996, developing a love for using computational and informatics tools to solve his in-the-lab chemistry challenges. Following roles at a number of Bay Area biotech startups as “the Med Chemist who also did computer stuff”, Whitney became a full-time Cheminformatics Scientist in 2003. A few years later he took a technical position at then-Accelrys, seeing our industry from a whole new perspective – the vendor side. In 2007, he transitioned to a sales role and has since held various regional and strategic positions at Accelrys, IDBS, Model N, and now Collaborative Dug Discovery. His responsibilities have included the sale and implementation of solutions across such highly diverse domains as cheminformatics, bioinformatics, GLP/GMP systems, business analytics, drug pricing, and revenue management. Whitney routinely engages with biotechs, big pharma, government, academic labs, and everyone in between to help solve their informatics, scientific, and business challenges.


 Session Abstract – PMWC 2022 Silicon Valley


The PMWC 2022 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.